Titanium dioxide nanostructures that reduce the infectivity of respiratory syncytial virus.

Antipathogenic surfaces Antiviral surfaces Bactericidal surfaces RSV TiO2 nanostructures

Journal

Materials today. Proceedings
ISSN: 2214-7853
Titre abrégé: Mater Today Proc
Pays: England
ID NLM: 101668762

Informations de publication

Date de publication:
23 Jun 2023
Historique:
medline: 15 4 2024
pubmed: 15 4 2024
entrez: 15 4 2024
Statut: aheadofprint

Résumé

The spread of respiratory diseases has gained significant attention since the detection and rapid global spread of COVID-19. Respiratory viruses are commonly transmitted when an infected person coughs or sneezes onto a surface, infecting persons who subsequently contact this surface. For this reason, developing surfaces with inherent antipathogenic properties is crucially needed for controlling the spread of deadly pathogens. Recent studies have established the antipathogenic potential of hydrothermally synthesised titanium dioxide (TiO

Identifiants

DOI: 10.1016/j.matpr.2023.05.711 PMID: 38620140 PMC: PMC10289122
pubmed: 38620140
doi: 10.1016/j.matpr.2023.05.711
pii: S2214-7853(23)03330-8
pmc: PMC10289122
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved. Selection and peer-review under responsibility of the scientific committee of the 16th Global Congress on Manufacturing and Management 2022.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Authors report financial support was provided by the Australia-India Strategic Research Fund and the Advance Queensland Industry Research Fellowship. There are no additional relationships, patents or activities to disclose.]

Auteurs

Alka Jaggessar (A)

Queensland University of Technology, School of Mechanical, Medical and Process Engineering, 2 George Street, Brisbane 4000, Australia.
Queensland University of Technology, Centre for Biomedical Technologies, 2 George Street, Brisbane 4000, Australia.

Amar Velic (A)

Queensland University of Technology, School of Mechanical, Medical and Process Engineering, 2 George Street, Brisbane 4000, Australia.
Queensland University of Technology, Centre for Biomedical Technologies, 2 George Street, Brisbane 4000, Australia.

Kirsten Spann (K)

Queensland University of Technology, School of Biomedical Science, 2 George Street, Brisbane 4000, Australia.
Queensland University of Technology, Centre for Immunology and Infection Control, 2 George Street, Brisbane 4000, Australia.

Prasad K D V Yarlagadda (PKDV)

University of Southern Queensland, School of Engineering, Springfield Central Queensland, 4300, Australia.

Classifications MeSH